Shares outstanding increased 405.6%
Shares outstanding changed +405.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +405.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating income changed -93.0% from the comparable as-filed period.
Trade receivables changed -51.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +71.7% from the comparable as-filed period.
Working capital changed +1268.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Current liabilities changed +61.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cash & equivalents changed +795.2% from the comparable as-filed period.
Stock-based compensation changed -28.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.